STOCK TITAN

Xos, Inc. Form 4 Filings

XOS NASDAQ

Every Form 4 that Xos, Inc. (XOS) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow XOS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full XOS filings page.

Rhea-AI Summary

Xos, Inc. Chief Financial Officer Liana Pogosyan had 3,163 shares withheld by the issuer on October 10, 2026, to satisfy tax withholding obligations tied to vesting of previously reported restricted stock unit awards. The reported price was $3.21 per share. Afterward, she directly held 559,483 shares, including 494,597 unvested RSUs.

Rhea-AI Summary

Xos, Inc. Chief Operating Officer and director Giordano Sordoni had 13,662 shares of common stock withheld on October 10, 2026, to satisfy tax-withholding obligations tied to vesting of previously reported restricted stock unit awards. The transaction lists a price of $3.21 per share. His reported post-transaction holdings were 2,914,427 shares, including 1,746,835 unvested RSUs; the filing states that certain securities included in the reported count are not beneficially owned under Rule 13d-3.

Rhea-AI Summary

Xos, Inc. (XOS) CEO and director Dakota Semler had 13,969 shares of common stock withheld by the issuer on October 10, 2026, to satisfy tax withholding obligations tied to vesting previously reported RSU awards. The reported price was $3.21 per share. His reported post-transaction position was 2,163,233 shares, including 1,750,453 unvested RSUs. A footnote says certain securities included in the reported position, such as RSUs vesting more than 60 days later, are not beneficially owned by him under Rule 13d-3 except to the extent of his pecuniary interest.

Rhea-AI Summary

Xos, Inc. director Edward J. Rapp acquired 1,814 shares of common stock on October 10, 2026, as RSUs issued in lieu of the cash retainer for his Q3 2026 non-employee director service; the RSUs vested immediately on the grant date. His direct holdings after the award were 196,428 shares, including 60,584 unvested RSUs. A separate indirect holding lists 21,172 shares in the Edward Joseph Rapp TTEE U/A dated February 7, 2005, of which he is trustee.

Rhea-AI Summary

Xos, Inc. Chief Financial Officer Liana Pogosyan was awarded 411,549 restricted stock units (RSUs) on September 10, 2026. On that date, 3,165 shares were withheld by the issuer for tax obligations tied to vesting previously reported RSUs; the transaction was reported at $2.79 per share. Her corrected total of unvested RSUs is 500,569, including 89,020 previously reported RSUs and the new award. The amendment reports no changes to the numbers of securities acquired, disposed of, or beneficially owned following the transactions.

Rhea-AI Summary

Xos, Inc. Chief Operating Officer and director Giordano Sordoni reported an award of 1,388,293 RSUs on September 10, 2026, and 13,662 shares withheld by the issuer to satisfy tax withholding obligations tied to vesting of previously reported RSUs. The amendment corrects the total unvested RSUs to 1,773,685, combining the 385,392 previously reported with the award; it states that transaction and post-transaction security counts are unchanged.

Rhea-AI Summary

Xos, Inc. Chief Executive Officer and director Dakota Semler amended his report to correct the unvested RSU total to 1,777,906. On September 10, 2026, Semler was awarded 1,388,293 RSUs, and the issuer withheld 14,538 shares to satisfy tax withholding obligations tied to previously reported RSUs. The amendment states that reported numbers of securities acquired, disposed of, or beneficially owned following transactions are unchanged.

Rhea-AI Summary

Xos, Inc. (symbol: XOS) is the issuer of record for a Form 4 filing submitted to the SEC. Xos, Inc. director George N. Mattson purchased 4,062 common shares at $2.60 per share on September 21, 2026. His reported direct position afterward was 196,408 shares, including 60,584 unvested RSUs. The reported holdings also include 131,250 shares held by NGAC NGM Feeder LLC and 33,333 held by GNM ICBC LLC. Mattson may be deemed to beneficially own those LLC-held shares through shared control of NGAC NGM Feeder LLC and control of GNM ICBC LLC, but disclaims beneficial ownership except to the extent of his pecuniary interest. No Rule 10b5-1 plan is reported.

Rhea-AI Summary

Xos, Inc. (XOS) director Dietmar Ostermann reported two open-market sales of common stock. On September 16, 2026, he sold 262 shares at $2.54 per share, and on September 17, 2026, he sold 4,738 shares at $2.5501 per share, totaling 5,000 shares sold. A footnote states that his reported holdings after these transactions include 60,584 unvested RSUs. No Rule 10b5-1 trading plan is indicated.

Rhea-AI Summary

Xos, Inc. (XOS) reported that its Chief Financial Officer, Liana Pogosyan, had 3,165 shares of common stock withheld on September 10, 2026 to satisfy tax withholding obligations from vesting Restricted Stock Units (RSUs), at a reference price of $2.79 per share. On the same date, she received a grant of 411,549 RSUs, of which 33% is scheduled to vest on March 10, 2027 and the remaining portion in 24 approximately equal monthly installments thereafter, subject to continued service. The filing does not indicate use of a Rule 10b5-1 trading plan.

Rhea-AI Summary

Xos, Inc. (XOS) reported that Chief Operating Officer and director Giordano Sordoni had 13,662 shares of common stock withheld on September 10, 2026 to pay tax liabilities arising from vesting of previously reported RSU awards at a reference price of $2.79 per share. On the same date he received a grant of 1,388,293 shares of common stock in connection with a Restricted Stock Unit (RSU) award, which vests with approximately 33% on March 10, 2027 and the remainder in 24 monthly installments thereafter, subject to continued service. No Rule 10b5-1 trading plan is reported for these transactions, and his reported holdings include 385,392 unvested RSUs that are not beneficially owned under Rule 13d-3.

Rhea-AI Summary

Xos, Inc. (XOS) disclosed that Chief Executive Officer and director Dakota Semler reported two equity-related transactions on September 10, 2026. The company withheld 14,538 shares of common stock to satisfy tax withholding obligations upon vesting of previously reported RSU awards. Semler also received a new grant of 1,388,293 RSUs, which vest approximately 33% on March 10, 2027, with the remainder vesting in 24 approximately equal monthly installments thereafter, subject to continued service. Footnotes state that Semler’s reported holdings include 389,613 unvested RSUs and clarify that certain securities are not beneficially owned within the meaning of Rule 13d-3 beyond his pecuniary interest.

Rhea-AI Summary

Xos, Inc. (XOS) director Dietmar Ostermann reported two open-market sales of common stock. On September 2, 2026, he sold 10,000 shares at a weighted average price of $3.02 per share, with actual prices ranging from $3.02 to $3.04. On September 4, 2026, he sold an additional 5,000 shares at $3.00 per share. No Rule 10b5-1 trading plan is reported, and his reported holdings after these transactions include 60,584 unvested RSUs, though the total share count is not stated.

Rhea-AI Summary

Xos, Inc. (XOS) director Alice Yake filed an amended Form 4 correcting prior transaction codes to show that three transactions in July 2026 were open-market sales (Code "S") of common stock, not dispositions to the issuer. Yake sold a total of 7,500 shares on July 15–17, 2026 under a Rule 10b5-1 trading plan adopted on September 29, 2025, at weighted average prices around $2.15–$2.30 per share. Reported holdings include 60,584 unvested RSUs.

Rhea-AI Summary

Xos, Inc. (XOS) reports that director Michael Paul Richardson sold a total of 9,356 shares of Common Stock in three open-market transactions on July 15–17, 2026, at weighted average prices around $2.11–$2.31 per share. The amendment clarifies these trades were Code “S” sales under a Rule 10b5-1 trading plan adopted on September 16, 2025, correcting an earlier miscoding as Code “D”, with no other changes to the original report. Post-transaction holdings include 60,584 unvested RSUs.

Rhea-AI Summary

Xos, Inc. (XOS) discloses an amended insider trading report for director Dietmar Ostermann. The amendment corrects prior transaction codes, clarifying that three July 2026 transactions were open-market sales (Code "S") rather than dispositions coded as "D". No other details from the original Form 4 are changed.

The director sold 4,159 shares of common stock on July 15, 2026 at a weighted average price of $2.3025 per share, 4,158 shares on July 16, 2026 at a weighted average of $2.1607, and 4,159 shares on July 17, 2026 at a weighted average of $2.1485. In total, 12,476 shares were sold pursuant to a Rule 10b5-1 trading plan adopted on September 16, 2025. A related footnote states the director’s holdings include 60,584 unvested RSUs.

Rhea-AI Summary

Xos, Inc. (XOS) reports an amended Form 4 for director Michael Paul Richardson, correcting prior transaction codes to reflect open‑market sales rather than dispositions to the issuer. On July 10, 13, and 14, 2026, he sold 3,119 shares of common stock on each date under a Rule 10b5-1 trading plan at weighted average prices around $2.35–$2.49 per share. On July 10, 2026, he also received a grant of 60,584 Restricted Stock Units (RSUs), which vest on the earlier of the first anniversary of the grant date or the day before Xos, Inc.'s 2027 annual meeting, subject to continued service. The amendment states no other information changes from the original Form 4.

Rhea-AI Summary

Xos, Inc. (XOS) director Dietmar Ostermann filed an amended Form 4 to correct prior coding of certain transactions from disposition code "D" to sale code "S". The filing reports a grant of 60,584 RSUs on July 10, 2026 and open-market sales totaling 12,475 shares of common stock on July 10, 13, and 14, 2026, all effected under a Rule 10b5-1 trading plan adopted on September 16, 2025. The RSUs vest on the earlier of the first anniversary of the grant date or the day before Xos, Inc.'s 2027 annual meeting, subject to Ostermann's continuous service.

Rhea-AI Summary

Xos, Inc. (XOS) reports an amended Form 4 for director Alice Yake, correcting prior transaction codes to reflect that certain dispositions were open‑market sales under a Rule 10b5-1 trading plan. On July 10, 2026 she received 60,584 RSUs subject to future vesting and 2,292 immediately vested RSUs in lieu of cash fees. She then sold 2,500 common shares on each of July 10, 13, and 14, 2026 at weighted average prices of $2.4916, $2.3483, and $2.3948 per share, respectively. The amendment states no other information from the original Form 4 has changed.

Rhea-AI Summary

Xos, Inc. (symbol: XOS) is the issuer of record for a Form 4 filing submitted to the SEC.

Rhea-AI Summary

Xos, Inc. (XOS) reported an insider transaction by Chief Operating Officer and director Giordano Sordoni. On 2026-08-20, he executed an open-market sale of 49,370 shares of Common Stock at a weighted average price of $4.0014 per share, with individual sale prices ranging from $4.00 to $4.03. Following this transaction, he directly holds 1,553,458 shares of Common Stock, which include 412,242 unvested RSUs.

Rhea-AI Summary

Xos, Inc. (XOS) director Dietmar Ostermann reported a sale of 10,000 shares of common stock on 2026-08-20 in an open-market or private transaction. The weighted average sale price was about $3.49 per share, with prices ranging from $3.49 to $3.50. Following this transaction, he directly holds 105,226 shares, which include 60,584 unvested RSUs.

Rhea-AI Summary

Xos, Inc. (XOS) director Stuart N. Bernstein reported selling 30,000 shares of Common Stock on 2026-08-18 in an open market or private transaction. The weighted average sale price was $4.1945 per share, with individual sales prices ranging from $4.125 to $4.39.

After this sale, Bernstein holds 112,642 shares directly, which include 60,584 unvested RSUs, and 4,133 shares indirectly through Bernstein Investment Partners LLC, where he is the Managing Member. The filing’s Rule 10b5-1 checkbox was not marked as being pursuant to a trading plan.

Rhea-AI Summary

Xos, Inc. Chief Executive Officer and director Dakota Semler reported a Form 4 transaction involving 14,538 shares of common stock on 2026-08-10. These shares were withheld by the company to satisfy tax withholding obligations arising from the vesting of previously reported Restricted Stock Unit (RSU) awards at a reference price of $2.70 per share. Following this tax-withholding disposition, Semler directly holds 803,447 shares of common stock, which include 417,067 unvested RSUs.

Rhea-AI Summary

Xos, Inc. director and Chief Operating Officer Giordano Sordoni reported a code F transaction involving company common stock. On 2026-08-10, 13,663 shares were withheld by the issuer at $2.70 per share to satisfy tax withholding obligations arising from the vesting of previously reported Restricted Stock Unit (RSU) awards. Following this tax-related withholding disposition, Sordoni directly holds 1,602,828 shares of common stock, which include 412,242 unvested RSUs, each RSU representing a contingent right to receive one share upon settlement.

Rhea-AI Summary

Xos, Inc. executive Liana Pogosyan, Chief Financial Officer, reported a Form 4 transaction involving company common stock. On 2026-08-10, 3,163 shares were disposed of at $2.70 per share to satisfy tax withholding obligations arising from the vesting of previously reported Restricted Stock Unit (RSU) awards. After this tax-withholding disposition, Pogosyan directly holds 154,262 shares of common stock, which include 94,994 unvested RSUs.

Rhea-AI Summary

Xos, Inc. director Michael Paul Richardson reported three dispositions of common stock on July 15–17, 2026, of 3,119, 3,119 and 3,118 shares at weighted average sale prices of $2.3067, $2.1674 and $2.1487 per share, effected under a Rule 10b5-1 trading plan adopted on September 16, 2025. Following these transactions, he directly owned 129,135 shares of common stock, including 60,584 unvested RSUs.

Rhea-AI Summary

Xos, Inc. director Alice Yake disposed of a total of 7,500 shares of common stock over three days from July 15–17, 2026, at weighted average prices of $2.3042, $2.1657 and $2.1481 per share, in transactions effected under a Rule 10b5-1 trading plan adopted on September 29, 2025. After these trades, she directly holds 152,561 shares, including 60,584 unvested RSUs.

Rhea-AI Summary

Xos, Inc. director Dietmar Ostermann disposed of a total of 12,476 shares of Common Stock over July 15–17, 2026 pursuant to a Rule 10b5-1 trading plan adopted on September 16, 2025. The shares were sold at weighted average prices with sale ranges between $2.11 and $2.34 per share. Following these transactions, he directly holds 115,226 shares, including 60,584 unvested RSUs.

Rhea-AI Summary

Xos, Inc. Chief Financial Officer Liana Pogosyan reported a tax-withholding disposition of 3,163 shares of common stock at $2.47 per share in connection with the vesting of previously reported RSU awards. The shares were withheld by the issuer to satisfy tax obligations. After this event, she holds 157,425 shares directly, including 100,966 unvested RSUs.

Rhea-AI Summary

Xos, Inc. Chief Operating Officer Giordano Sordoni reported a tax-withholding disposition of 9,916 shares of common stock on 2026-07-10, representing shares withheld by the issuer to satisfy tax obligations upon vesting of previously reported RSU awards at $2.47 per share. Following this withholding, he holds 1,616,491 shares of common stock directly, including 439,093 unvested RSUs, with each RSU representing a contingent right to receive one share upon settlement.

Rhea-AI Summary

Xos, Inc. Chief Executive Officer Dakota Semler reported a tax-withholding disposition of 14,538 shares of common stock on July 10, 2026 at $2.47 per share. The shares were withheld by the company to satisfy tax obligations upon vesting of previously granted RSU awards. After this transaction, Semler directly holds 817,985 shares, including 444,521 unvested RSUs, each representing a contingent right to receive one share upon settlement.

Rhea-AI Summary

Xos, Inc. director Alice Yake reported both equity awards and share disposals in common stock. On July 10, 2026 she received a grant of 60,584 Restricted Stock Units (RSUs) that vest on the earlier of the first anniversary of grant or the day before the 2027 annual meeting, subject to continued service, plus 2,292 RSUs issued in lieu of second‑quarter 2026 cash director and committee chair fees that vested immediately. She disposed of 2,500 shares on each of July 10, 13 and 14 at weighted‑average prices between $2.325 and $2.59 per share, with at least one transaction effected under a Rule 10b5‑1 trading plan adopted September 29, 2025. After these transactions she directly holds 160,061 common shares, including 60,584 unvested RSUs.

Rhea-AI Summary

Xos, Inc. director Dietmar Ostermann reported a mixed equity update. He received a grant of 60,584 Restricted Stock Units (RSUs), each representing a contingent right to one future share, while disposing of a total of 12,475 common shares in three disposition transactions at weighted average prices of $2.4937, $2.3457, and $2.3913 per share. After these transactions, he directly holds 127,702 common shares, including 60,584 unvested RSUs, with at least one disposition executed under a Rule 10b5-1 trading plan adopted on September 16, 2025.

Rhea-AI Summary

Xos, Inc. director Michael Paul Richardson reported a compensation-related grant of 60,584 Restricted Stock Units, each representing a contingent right to receive one share of common stock. These RSUs vest on the earlier of the first anniversary of the grant date or the day before the company’s 2027 annual meeting, subject to his continuous service.

He also disposed of 3,119 shares on each of 2026-07-10, 2026-07-13, and 2026-07-14 at weighted average prices of 2.4935, 2.3473, and 2.3899 per share, with sale prices disclosed in specified ranges and at least one transaction under a Rule 10b5-1 trading plan adopted on 2025-09-16. After these transactions, he holds 138,491 shares directly, including 60,584 unvested RSUs.

Rhea-AI Summary

Bernstein Stuart N. reported acquisition or exercise transactions in this Form 4 filing.

Xos, Inc. director Stuart N. Bernstein reported an equity compensation award and updated holdings. He received 60,584 Restricted Stock Units (RSUs), each a contingent right to one share of common stock, vesting on the earlier of the first anniversary of the grant date or the day before the company’s 2027 Annual Meeting, subject to continuous service. Following this grant, Bernstein holds 142,642 shares of common stock directly (including 60,584 unvested RSUs) and 4,133 shares indirectly through Bernstein Investment Partners LLC.

Rhea-AI Summary

Mattson George N reported acquisition or exercise transactions in this Form 4 filing.

Xos, Inc. director George N. Mattson received an equity award of 60,584 restricted stock units, each representing a contingent right to one share of common stock. These RSUs vest on the earlier of the first anniversary of the grant date and the day before the 2027 annual meeting, subject to his continuous service. Following this grant, he holds 192,346 common shares directly, including the unvested RSUs, and has indirect interests in 131,250 and 33,333 shares through NGAC GNM Feeder LLC and GNM ICBC LLC, for which he disclaims beneficial ownership beyond his pecuniary interest.

Rhea-AI Summary

RAPP EDWARD J reported acquisition or exercise transactions in this Form 4 filing.

Xos, Inc. director Edward J. Rapp received equity compensation in the form of restricted stock units. He was granted 60,584 RSUs that vest on the earlier of the first anniversary of the grant date or the day before the 2027 annual meeting, subject to continued service, and 2,670 RSUs issued in lieu of his second-quarter 2026 cash retainer as a non-employee director and Audit Committee Chair, which vested immediately on grant. He also reports 21,172 shares of common stock held indirectly through a trust for which he serves as trustee.

Rhea-AI Summary

Smith John F. reported acquisition or exercise transactions in this Form 4 filing.

Xos, Inc. director Smith John F. received a grant of 60,584 Restricted Stock Units, each representing one share of common stock upon settlement. These RSUs vest on the earlier of the first anniversary of the grant date or the day before the 2027 Annual Meeting, subject to the reporting person's continuous service, and bring direct holdings to 113,562 shares, including 60,584 unvested RSUs.

Rhea-AI Summary

Xos, Inc. director Stuart N. Bernstein reported an open-market sale of 2,000 shares of Common Stock on June 30, 2026 at $2.89 per share. After this transaction, he directly holds 82,058 shares.

The filing also shows an additional 4,133 shares of Common Stock held indirectly through Bernstein Investment Partners LLC, of which he is the Managing Member, according to the footnote. Within this filing, the sale represents a small fraction of his reported shareholdings.

Rhea-AI Summary

Xos, Inc. Chief Executive Officer Dakota Semler reported a routine tax-related share disposition. On this Form 4, 14,538 shares of common stock were withheld by the company at $3.66 per share to cover tax obligations tied to previously granted Restricted Stock Unit (RSU) awards.

These shares were not sold in the open market, but retained by the issuer to satisfy withholding requirements when RSUs vested. After this transaction, Semler directly holds 832,523 shares of common stock, and the position also includes 471,975 unvested RSUs that may settle into additional shares over time.

Rhea-AI Summary

Xos, Inc. director and Chief Operating Officer Giordano Sordoni reported a tax-related share disposition tied to vested equity awards. The company withheld 9,636 shares of common stock at $3.66 per share to cover tax obligations from vesting Restricted Stock Unit (RSU) awards, rather than an open-market sale. After this withholding, Sordoni directly owns 1,626,407 shares of Xos common stock, which includes 465,944 unvested RSUs that may convert into additional shares as they vest.

Rhea-AI Summary

Xos, Inc. Chief Financial Officer Liana Pogosyan had 3,164 shares of common stock withheld by the company at $3.66 per share to satisfy tax obligations tied to vesting of previously reported Restricted Stock Unit (RSU) awards. This is a tax-withholding disposition, not an open-market sale. Following the withholding, she directly holds 160,588 shares of common stock, which include 106,938 unvested RSUs that may convert into an equal number of shares as they vest.

Rhea-AI Summary

Xos, Inc. director Dietmar Ostermann reported an open-market sale of 3,351 shares of Common Stock on 2026-06-08 at a weighted average price of $4.4512 per share. Footnotes state the shares were sold at prices ranging from $4.1785 to $5.1205. After this transaction, he directly holds 79,593 shares, which includes 62,377 unvested RSUs, so the sale represents only a portion of his overall stake.

Rhea-AI Summary

Xos, Inc. director Stuart N. Bernstein reported an open-market sale of 4,000 shares of common stock on June 4, 2026 at a weighted average price of $5.2563 per share, with trade prices ranging from $5.07 to $5.4425.

Following the sale, he holds 84,058 shares of Xos common stock directly, which include 62,377 unvested RSUs. He also reports 4,133 shares held indirectly through Bernstein Investment Partners LLC, where he is the managing member.

Rhea-AI Summary

Emerald Green Trust, previously a 10% owner of Xos, Inc., reported open-market sales totaling 400,000 shares of common stock on June 3–4, 2026 at weighted-average prices in the mid-$5 to mid-$6 range, pursuant to a Rule 10b5-1 trading plan established on November 21, 2025.

After these transactions, Emerald Green Trust directly holds 1,161,229 shares of Xos common stock, and the disclosure states that following the June 4, 2026 trades it ceased to be a beneficial owner of 10% or more of the outstanding common stock and is no longer subject to Section 16 reporting.

Rhea-AI Summary

Xos, Inc. Chief Executive Officer and director Dakota Semler reported a bona fide gift of 30,000 shares of Common Stock. The transfer was a gift to several persons who are not immediate family members and did not involve a sale or purchase in the market.

After the gift, Semler holds 847,061 shares of Xos common stock directly, which include 499,430 unvested restricted stock units (RSUs). This filing mainly updates Semler’s reported ownership and reflects a non-cash, non-market disposition.

Rhea-AI Summary

Xos, Inc. director Stuart N. Bernstein reported an open-market sale of 4,921 shares of Common Stock on May 20, 2026 at a weighted average price of $2.0006 per share, with trades ranging from $2.00 to $2.0015.

After the sale, he directly holds 88,058 shares, which include 62,377 unvested RSUs, and indirectly holds 4,133 shares through Bernstein Investment Partners LLC, where he is the Managing Member. The sale represents a relatively small portion of his overall direct holdings.

Rhea-AI Summary

Xos, Inc. director Stuart N. Bernstein reported an open-market sale of 5,179 shares of Common Stock on March 31, 2026 at a weighted average price of about $1.6418 per share. Following the sale, he holds 92,979 shares directly, which include 62,377 unvested RSUs, and 4,133 shares indirectly through Bernstein Investment Partners LLC.

Rhea-AI Summary

Xos, Inc. director and Chief Operating Officer Giordano Sordoni reported a routine tax-related share disposition. On this Form 4/A, 9,637 shares of common stock were withheld by the company at a price of $1.89 per share to cover tax obligations from vesting Restricted Stock Units (RSUs).

After this withholding, Sordoni directly holds 1,636,043 shares of Xos common stock, which includes 492,795 unvested RSUs that may convert into additional shares as they vest. This event reflects compensation-related tax settlement rather than an open-market sale.